1. Home
  2. BCYC vs MUX Comparison

BCYC vs MUX Comparison

Compare BCYC & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • MUX
  • Stock Information
  • Founded
  • BCYC 2009
  • MUX 1979
  • Country
  • BCYC United Kingdom
  • MUX Canada
  • Employees
  • BCYC N/A
  • MUX N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • MUX Precious Metals
  • Sector
  • BCYC Health Care
  • MUX Basic Materials
  • Exchange
  • BCYC Nasdaq
  • MUX Nasdaq
  • Market Cap
  • BCYC 529.8M
  • MUX 579.8M
  • IPO Year
  • BCYC 2019
  • MUX N/A
  • Fundamental
  • Price
  • BCYC $7.10
  • MUX $10.86
  • Analyst Decision
  • BCYC Buy
  • MUX Strong Buy
  • Analyst Count
  • BCYC 12
  • MUX 2
  • Target Price
  • BCYC $22.91
  • MUX $16.00
  • AVG Volume (30 Days)
  • BCYC 261.8K
  • MUX 1.1M
  • Earning Date
  • BCYC 08-08-2025
  • MUX 08-06-2025
  • Dividend Yield
  • BCYC N/A
  • MUX N/A
  • EPS Growth
  • BCYC N/A
  • MUX N/A
  • EPS
  • BCYC N/A
  • MUX N/A
  • Revenue
  • BCYC $19,281,000.00
  • MUX $168,169,000.00
  • Revenue This Year
  • BCYC $7.35
  • MUX $1.09
  • Revenue Next Year
  • BCYC N/A
  • MUX N/A
  • P/E Ratio
  • BCYC N/A
  • MUX N/A
  • Revenue Growth
  • BCYC N/A
  • MUX N/A
  • 52 Week Low
  • BCYC $6.10
  • MUX $6.38
  • 52 Week High
  • BCYC $28.67
  • MUX $11.80
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 37.11
  • MUX 54.69
  • Support Level
  • BCYC $7.25
  • MUX $9.87
  • Resistance Level
  • BCYC $7.68
  • MUX $11.30
  • Average True Range (ATR)
  • BCYC 0.42
  • MUX 0.51
  • MACD
  • BCYC -0.07
  • MUX 0.02
  • Stochastic Oscillator
  • BCYC 12.80
  • MUX 70.51

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

Share on Social Networks: